Ramos EL - Search Results

1

Report of the Third Banff Conference on Allograft Pathology (July 20-24, 1995) on classification and lesion scoring in renal allograft pathology.

Solez K, Benediktsson H, Cavallo T, Croker B, Demetris AJ, Drachenberg C, Emancipator S, Furness PN, Gaber LW, Gibson IW, Gough J, Gupta R, Halloran P, Häyry P, Kashgarian M, Marcussen N, Massy ZA, Mihatsch MJ, Morozumi K, Noronha I, Olsen S, Papadimitriou J, Paul LC, Picken M, Racusen LC, Ramos EL, Randhawa P, Rayner DC, Rush D, Sanfilippo F, Taskinen E, Trpkov K, Truong L, Yamaguchi Y, Yilmaz S. Solez K, et al. Among authors: ramos el. Transplant Proc. 1996 Feb;28(1):441-4. Transplant Proc. 1996. PMID: 8644308 No abstract available.

2

Thromboxane synthase expression in renal transplant patients with rejection.

Ramos EL, Barri YM, Croker BP, Clapp WL, Peterson JC, Wilcox CS. Ramos EL, et al. Transplantation. 1995 Feb 27;59(4):490-4. Transplantation. 1995. PMID: 7878751

3

Delayed graft function is associated with an increased incidence of occult rejection and results in poorer graft survival.

Howard RJ, Pfaff WW, Brunson ME, Ramos EL, Peterson JC, Croker BP, Scornik JC, Parris CJ, Fennell RS. Howard RJ, et al. Among authors: ramos el. Transplant Proc. 1993 Feb;25(1 Pt 2):884. Transplant Proc. 1993. PMID: 8442256 No abstract available.

4

Thromboxane synthase expression co-localizes with infiltrating macrophages in renal allograft biopsies.

Berkes EA, Croker BP, Barri YM, Peterson JC, Wilcox CS, Ramos EL. Berkes EA, et al. Among authors: ramos el. Kidney Int. 1995 Oct;48(4):1344-6. doi: 10.1038/ki.1995.420. Kidney Int. 1995. PMID: 8569098 Free article. No abstract available.

5

Increased incidence of rejection in patients with delayed graft function.

Howard RJ, Pfaff WW, Brunson ME, Scornik JC, Ramos EL, Peterson JC, Fennell RS, Croker BP. Howard RJ, et al. Among authors: ramos el. Clin Transplant. 1994 Dec;8(6):527-31. Clin Transplant. 1994. PMID: 7865914

6

Protocol core needle biopsy and histologic Chronic Allograft Damage Index (CADI) as surrogate end point for long-term graft survival in multicenter studies.

Yilmaz S, Tomlanovich S, Mathew T, Taskinen E, Paavonen T, Navarro M, Ramos E, Hooftman L, Häyry P. Yilmaz S, et al. J Am Soc Nephrol. 2003 Mar;14(3):773-9. doi: 10.1097/01.asn.0000054496.68498.13. J Am Soc Nephrol. 2003. PMID: 12595515

7

Colchicine neuromyopathy in a renal transplant patient with normal muscle enzyme levels.

Cook M, Ramos E, Peterson J, Croker B. Cook M, et al. Clin Nephrol. 1994 Jul;42(1):67-8. Clin Nephrol. 1994. PMID: 7923972 No abstract available.

8

Early experience with anti-Tac in clinical renal transplantation.

Kirkman RL, Shapiro ME, Carpenter CB, Milford EL, Ramos EL, Tilney NL, Waldmann TA, Zimmerman CE, Strom TB. Kirkman RL, et al. Among authors: ramos el. Transplant Proc. 1989 Feb;21(1 Pt 2):1766-8. Transplant Proc. 1989. PMID: 2652578 Clinical Trial. No abstract available.

9

Differential IL-2 receptor expression in renal allograft recipients treated with an anti-IL-2-receptor antibody.

Ramos EL, Milford EL, Kirkman RL, Tilney NL, Strom TB, Shapiro ME, Waldmann TA, Wood IG, Rollins MR, Carpenter CB. Ramos EL, et al. Transplantation. 1989 Sep;48(3):415-20. doi: 10.1097/00007890-198909000-00012. Transplantation. 1989. PMID: 2571203 Clinical Trial.

10

A randomized prospective trial of anti-Tac monoclonal antibody in human renal transplantation.

Kirkman RL, Shapiro ME, Carpenter CB, McKay DB, Milford EL, Ramos EL, Tilney NL, Waldmann TA, Zimmerman CE, Strom TB. Kirkman RL, et al. Among authors: ramos el. Transplant Proc. 1991 Feb;23(1 Pt 2):1066-7. Transplant Proc. 1991. PMID: 1989150 Clinical Trial. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

56 results

Search Page

Filters